Clinical Trial: An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United States
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Non-metastatic Prostate Cancer
Study Type: OBSERVATIONAL
Official Title: ARI Treatment Use and Outcomes in Non-metastatic Prostate Cancer (nmPC) Patients in the US
Brief Summary:
This is an observational study in which data will be collected and studied from men with non-metastatic prostate cancer (nmPC) who received their usual treatment with 'androgen receptor inhibitors' (ARIs) including darolutamide, enzalutamide, and apalutamide.Prostate cancer is a common cancer in men that starts in the prostate gland, a male reproductive gland found below the bladder.Non-metastatic means that cancer has not yet spread to other parts of the body.Darolutamide, enzalutamide, and apalutamide…
Read more